Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Dr. Oz Show Launches "IT'S NOT ME" Campaign To Inform And Warn Viewers About Rogue Marketers Engaging In Copyright Infringement And Illegal Use Of The Dr. Oz Name

Disclaimer to Run in Show Beginning Monday, May 6

The Dr. Oz Show. (PRNewsFoto/Sony Pictures Television) (PRNewsFoto/)

News provided by

The Dr. Oz Show

May 05, 2013, 09:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, May 5, 2013 /PRNewswire/ -- The two-time Emmy® Award-winning, nationally syndicated hit daytime series The Dr. Oz Show is launching an aggressive campaign to fight copyright infringement and illegal use of the Dr. Oz name, image and show beginning Monday, May 6.

(Logo: http://photos.prnewswire.com/prnh/20110909/LA65382LOGO)

In an effort to inform viewers and protect them from rogue vitamin and supplement company marketing campaigns that illegally use the Dr. Oz name, beginning May 6, Dr. Mehmet Oz will end each show with a disclaimer that reads:

"If you receive an e-mail or any kind of direct marketing claiming to be from me selling a product with my name, my image or the show's name, you need to know IT'S NOT ME!  I consider anyone that uses my name or my picture to try to sell you a product or supplement reckless and dangerous. They are undermining my credibility with you and the trust you place in me.  More importantly, it could be dangerous to your health. Please go to doctoroz.com/oz-watch to report if you receive any messages that use me to sell you anything. To see a list of our trusted partners, please go to Dr. Oz.com."

Over 11,000 complaints have been logged through the OzWatch portal on www.doctoroz.com, which is devoted to detecting and enforcing infringement.

"Today I am taking back my name and protecting my viewers from people I consider dangerous, who try to mislead you into buying products I don't endorse," said host Mehmet Oz, M.D. "Anything you see on this show is part of a conversation I am having with you about your health.  We are always transparent about our trusted, official partnerships and a full list of these partners is available on our website."

Over the past several years, ubiquitous banner ads featuring Dr. Oz endorsements have saturated the internet, embedded through sites like Facebook, Google, Amazon and YouTube targeting consumers with misleading advertising for products that may have been seen on the show.  Recently, e-mail spamming, targeted ads and robo-calling have all been reported by viewers. As a result, the first show of Season 4 in September 2012 addressed this issue and launched "OzWatch" on the doctoroz.com web site, where viewers could report violations and turn in e-mails they received.

The Dr. Oz Show has produced close to 700 shows in four seasons that bring new actionable information that the perpetrators can deploy immediately. Items mentioned on the 700 "The Dr. Oz Show's" produced over the past four seasons that have resulted in the largest organized fraudulent efforts include green coffee bean extract, raspberry ketones and garcinia cambogia.

About The Dr. Oz Show

The two-time Daytime Emmy® Award-winning The Dr. Oz Show, hosted by the two-time Daytime Emmy Award-winning host, Dr. Mehmet Oz, is now in its fourth season.  The Dr. Oz Show, which is currently seen in 118 countries worldwide, debuted domestically in 2009 with the biggest ratings in nine years in daytime television.

Dr. Oz, the world-renowned cardiothoracic surgeon, served as health expert on "The Oprah Winfrey Show" since 2004, sharing advice with viewers to help them live their best life from the inside out. Dr. Oz has co-authored six New York Times Best Sellers including "YOU: The Owner's Manual", "YOU: The Smart Patient", "YOU: On a Diet", "YOU: Staying Young", "YOU: Being Beautiful" and "YOU Having a Baby" as well as the award-winning "Healing from the Heart". He has a regular column in TIME Magazine and O The Oprah Magazine. 

Dr. Oz is vice-chair of the Department of Surgery and Professor of Surgery at Columbia University.  He directs the Cardiovascular Institute and Complementary Medicine Program at New York Presbyterian Hospital and performs 100 heart operations annually. His research interests include heart replacement surgery, minimally invasive cardiac surgery, complementary medicine and health care policy. He has authored over 400 original publications, book chapters, and medical books and has received several patents.

Cleared in over 99% of the country, The Dr. Oz Show is co-produced by Harpo Productions and Sony Pictures Television (SPT) and distributed by SPT.  The Dr. Oz Show is executive produced by Mindy Borman and Amy Chiaro.  The show is filmed in front of a studio audience in Studio 6A in New York's legendary Rockefeller Center.

About Harpo Studios

Harpo Studios is the multi-award winning production company which creates original television programming for OWN: Oprah Winfrey Network, including the popular series "Oprah's Next Chapter," "Oprah's Master Class," "Oprah's Lifeclass," "Iyanla: Fix My Life," and the Emmy® Award-winning "Super Soul Sunday."  Oprah Winfrey's creative instincts inform the brand, co-producing the highly-rated syndicated talk shows "The Dr. Oz Show," "Dr. Phil," and "Rachael Ray."  For 25 years, Harpo produced the number-one-rated, award-winning "The Oprah Winfrey Show."  Harpo Print, LLC and Hearst Magazines publish the monthly O, The Oprah Magazine publication, while Harpo Films is dedicated to high-quality scripted dramatic programming, and Harpo Radio, Inc. produces Oprah Radio on Sirius XM Radio (XM Channel 111 and Sirius Channel 204).

About Sony Pictures Television

Sony Pictures Television (http://www.sonypicturestelevision.com), a Sony Pictures Entertainment company, is one of the television industry's leading content providers. It produces and distributes programming in every genre, around the world and for a multitude of platforms.  In addition to one of the industry's largest libraries of award-winning feature films, television shows and formats, Sony Pictures Television (SPT) boasts a current program slate that includes top-rated daytime dramas and game shows, landmark off-network series, original animated series and critically acclaimed primetime dramas, comedies and telefilms. SPT has 18 wholly-owned or joint venture production companies in 13 countries outside the U.S. and also maintains offices in 33 countries. SPT's worldwide television networks portfolio includes 124 channel feeds available in 159 countries, reaching more than 840 million households worldwide.  SPT also creates original content for and manages SPE's premium video website, Crackle. Additionally, SPT owns production company Embassy Row and is a part owner of cable channel Game Show Network (GSN), 3D channel 3net, premier horror/thriller website and VOD service FEARnet and national U.S media sales company ITN Networks, Inc.  SPT advertiser sales is one of the premier national advertising sales companies and handles the commercial inventory in SPT's syndicated series as well as in U.S. digital businesses including FEARnet, DrOz.com and PlayStation.

SOURCE The Dr. Oz Show

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.